LYMPHOSTAT- B Trademark

Trademark Overview

On Thursday, July 12, 2001, a trademark application was filed for LYMPHOSTAT- B with the United States Patent and Trademark Office. The USPTO has given the LYMPHOSTAT- B trademark a serial number of 76283659. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 10, 2015. This trademark is owned by Human Genome Sciences, Inc.. The LYMPHOSTAT- B trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancers and diseases and disorders of the immune system
lymphostat- b

General Information

Serial Number76283659
Word MarkLYMPHOSTAT- B
Filing DateThursday, July 12, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 10, 2015
Registration Number2908983
Registration DateTuesday, December 7, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 5, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancers and diseases and disorders of the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 10, 2015
Primary Code005
First Use Anywhere DateTuesday, September 30, 2003
First Use In Commerce DateTuesday, September 30, 2003

Trademark Owner History

Party NameHuman Genome Sciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Friday, July 10, 2015CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Tuesday, June 9, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 9, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 6, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 6, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 14, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, December 10, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 23, 2010TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 11, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 7, 2004REGISTERED-PRINCIPAL REGISTER
Monday, October 4, 2004LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, September 24, 2004ASSIGNED TO LIE
Tuesday, September 21, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 13, 2004ASSIGNED TO EXAMINER
Thursday, September 9, 2004STATEMENT OF USE PROCESSING COMPLETE
Friday, July 16, 2004USE AMENDMENT FILED
Monday, August 16, 2004EXTENSION 3 GRANTED
Friday, July 16, 2004EXTENSION 3 FILED
Tuesday, August 3, 2004CASE FILE IN TICRS
Friday, July 16, 2004PAPER RECEIVED
Wednesday, February 18, 2004EXTENSION 2 GRANTED
Wednesday, January 28, 2004EXTENSION 2 FILED
Wednesday, January 28, 2004PAPER RECEIVED
Tuesday, July 29, 2003EXTENSION 1 GRANTED
Wednesday, July 9, 2003EXTENSION 1 FILED
Wednesday, July 9, 2003PAPER RECEIVED
Tuesday, January 28, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2002PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2002NOTICE OF PUBLICATION
Tuesday, August 27, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 12, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 20, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 29, 2001NON-FINAL ACTION MAILED
Saturday, August 25, 2001ASSIGNED TO EXAMINER

Related Keywords

lymphostat disorders immune system diseases cancers preparations treatment pharmaceutical